Valo Health to Present at the 41st Annual J.P. Morgan Healthcare Conference January 10, 2023 • Jennifer Hanley
Valo Health To Participate in Piper Sandler's 34th Annual Healthcare Conference December 1, 2022 • Jennifer Hanley
Valo Health to Participate in UBS Biotechnology Virtual Private Company Symposium September 22, 2022 • Jennifer Hanley
Cardiac Drug Discovery Reignited: New Tools Unlock Genetically Defined Diseases August 9, 2022 • Valo Health
Valo Health - FDA Collaborative Study in Human Cardiac Tissues Demonstrates Potential to Predict Clinical Efficacy of Cardiac Contractility Modulation Devices to Treat Heart Failure
